International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1).

Kazuhiro YoshidaItaru YasufukuMasanori TerashimaSun Young RhaJae Moon BaeGuoxin LiHitoshi KataiMasahiko WatanabeYasuyuki SetoSung Hoon NohHan- Kwang YangJiafu JiHideo BabaYuko KitagawaSatoshi MoritaMasahiko NishiyamaYasuhiro Koderanull null

Published in: Annals of gastroenterological surgery (2021)

Conversion therapy for stage IV gastric cancer is safe and could be a new therapeutic strategy to improve the survival of patients, especially those with R0 resection.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes